The authors of an analysis of thousands of medical records across four U.S. communities said Thursday they've found further ...

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

A LinkedIn survey found that 54% of U.S. workers want to change jobs in 2025. Career expert Catherine Fisher shares strategies to stand out in a competitive market. AccuWeather's Tony Laubach breaks ...

Popular diabetes and weight loss drugs may do more than curb appetites — they may also help reduce the risk of dementia, according to new research. Two studies that noted this unexpected effect ...

Weight loss jabs could cut the risk of dementia - the leading cause of death in the UK - a new study has found. GLP-1RAs is a ...

It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

Obesity and diabetes drugs, particularly semaglutides like Wegovy and Ozempic, may reduce a person’s risk of dementia, a new ...

Recent findings suggest that popular diabetes and weight-loss drugs may also lower the risk of developing ... an attractive approach to expedite the discovery of new treatments for dementia. Newer ...